Rocket Pharmaceuticals, Inc. (RCKT) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -45.39M | -34.84M | -50.43M | -48.96M | -55.8M | -46.96M | -52.1M | -53.85M | -56.88M | -29.37M | -57.15M | -50.87M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 18.65% | 25.8% | 3.21% | 9.08% | 1.9% | -59.89% | 8.83% | -5.86% | 1.24% | 47.61% | -30.3% | -30.3% |
| Net Income | -47.59M | -42.54M | -50.33M | -68.92M | -61.33M | -60.33M | -66.72M | -69.65M | -62.05M | -59.66M | -61.9M | -65.7M |
| Depreciation & Amortization | 2.15M | 2.22M | 3.24M | 2.58M | 2.99M | 2.36M | 2.42M | 2.37M | 2.25M | 2.37M | 1.76M | 1.73M |
| Stock-Based Compensation | 8.49M | 6.11M | 9.76M | 10.86M | 10.33M | 11.09M | 11.25M | 11.33M | 10.25M | 0 | 10.32M | 10.24M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.47M | 0 |
| Other Non-Cash Items | -1.02M | -826K | -1.6M | -2.21M | -2.08M | 653K | 699K | -2.24M | -2.75M | 6.43M | -13.85M | -2.49M |
| Working Capital Changes | -7.42M | 195K | -11.5M | 8.73M | -5.71M | -732K | 248K | 4.33M | -4.58M | 21.5M | -5.94M | 5.34M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 17.45M | 36.42M | 93.62M | 31.76M | -58.03M | -37.87M | 78.92M | 55.62M | 35.03M | -140.81M | 48.25M | 31.21M |
| Capital Expenditures | -93K | -80K | 54K | -50K | -364K | -309K | -1.59M | -1.93M | -2.04M | -4.65M | -4.66M | -4.15M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -52.91K | -35.33K |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 52.91K | 35.33K |
| Cash from Financing | -1K | 0 | -59K | 215K | 12K | 182.86M | 176K | 1.56M | 1.21M | 421K | 189.49M | 182K |
| Debt Issued (Net) | -1K | 0 | 8K | 13K | 12K | 15K | 24K | 29K | 27K | 30K | 35K | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 215K | 0 | 182.85M | 176K | 1.53M | 1.18M | 391K | 189.49M | 182K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | -67K | -13K | 0 | 0 | -24K | 0 | 0 | 0 | -35K | 0 |
| Net Change in Cash | -27.95M | 1.58M | 43.13M | -16.99M | -113.83M | 98.04M | 26.99M | 3.33M | -20.63M | -169.75M | 180.59M | -19.48M |
| Free Cash Flow | -45.49M | -34.92M | -50.37M | -49.01M | -56.17M | -47.27M | -53.69M | -55.78M | -58.92M | -34.02M | -61.8M | -55.02M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 19.01% | 26.12% | 6.18% | 12.13% | 4.67% | -38.95% | 13.13% | -1.39% | 2.81% | 42.66% | -39.32% | -31.19% |
| FCF per Share | -0.41 | -0.31 | -0.45 | -0.44 | -0.51 | -0.48 | -0.57 | -0.60 | -0.63 | -0.36 | -0.75 | -0.68 |
| FCF Conversion (FCF/Net Income) | 0.95x | 0.82x | 1.00x | 0.71x | 0.91x | 0.78x | 0.78x | 0.77x | 0.92x | 0.49x | 0.92x | 0.77x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |